Skip to content

Clinical trials

Completed Adenocarcinoma trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Completed Country / region: Russia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20093
20102
20161
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
AO GENERIUM1
AstraZeneca1
Boehringer Ingelheim1
Clovis Oncology, Inc.1
NantCell, Inc.1
Novartis Pharmaceuticals1
Pfizer1
Regeneron Pharmaceuticals1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma11
Neoplasm Metastasis4
Neoplasms4
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Neoplasms by Histologic Type2
Stomach Neoplasms2
Carcinoma1
Carcinoma, Pancreatic Ductal1
Colonic Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.